| NCT03394755 |
Thrombosomes® in Bleeding Thrombocytopenic Patients |
https://ClinicalTrials.gov/show/NCT03394755 |
Active, not recruiting |
Cellphire, Inc. |
2019-08-03 |
| NCT01768845 |
Unrelated Umbilical Cord Blood (UBC)Transplantation |
https://ClinicalTrials.gov/show/NCT01768845 |
Active, not recruiting |
West Virginia University |
2019-05-14 |
| NCT03825744 |
Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT03825744 |
Recruiting |
Jiangsu HengRui Medicine Co., Ltd. |
2021-02-28 |
| NCT03821987 |
Risk Stratification Directed Conditioning Regimen for Haploidentical HSCT in SAA |
https://ClinicalTrials.gov/show/NCT03821987 |
Recruiting |
Peking University People’s Hospital |
2021-12-30 |
| NCT03333486 |
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer |
https://ClinicalTrials.gov/show/NCT03333486 |
Recruiting |
Roswell Park Cancer Institute |
2022-09-06 |
| NCT03318159 |
Posaconazole Prophylaxis During ATG Treatment for hMDS/AA Patients |
https://ClinicalTrials.gov/show/NCT03318159 |
Recruiting |
Seoul National University Hospital |
2019-06-30 |
| NCT03246178 |
Haploidentical Transplantation in Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT03246178 |
Enrolling by invitation |
Chinese PLA General Hospital |
2020-07-01 |
| NCT03218657 |
Clinical Study of Non Severe Aplastic Anemia Treated With Cyclosporine, Androgen and Levamisole |
https://ClinicalTrials.gov/show/NCT03218657 |
Recruiting |
Zhejiang Provincial Hospital of TCM |
2019-07-01 |
| NCT03176849 |
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT |
https://ClinicalTrials.gov/show/NCT03176849 |
Enrolling by invitation |
Phoenix Children’s Hospital |
2019-09-01 |
| NCT03173937 |
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome |
https://ClinicalTrials.gov/show/NCT03173937 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-04-29 |
| NCT03243656 |
Eltrombopag in Children With Idiopathic Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT03243656 |
Recruiting |
Assiut University |
2020-12-31 |
| NCT03025698 |
A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT03025698 |
Recruiting |
Novartis |
2025-04-01 |
| NCT03016806 |
Umbilical Cord Blood Transplantation From Unrelated Donors |
https://ClinicalTrials.gov/show/NCT03016806 |
Recruiting |
University of Rochester |
2025-06-30 |
| NCT02998645 |
Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT02998645 |
Recruiting |
Novartis |
2020-11-19 |
| NCT02979873 |
Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy |
https://ClinicalTrials.gov/show/NCT02979873 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-08-31 |
| NCT02960646 |
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT02960646 |
Recruiting |
M.D. Anderson Cancer Center |
2020-11-30 |
| NCT02928991 |
Fludarabine Based RIC for Bone Marrow Failure Syndromes |
https://ClinicalTrials.gov/show/NCT02928991 |
Recruiting |
Children’s Hospital of Philadelphia |
2020-04-30 |
| NCT02918292 |
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) |
https://ClinicalTrials.gov/show/NCT02918292 |
Recruiting |
Medical College of Wisconsin |
2021-02-28 |
| NCT02875743 |
King’s Invasive Aspergillosis Study II |
https://ClinicalTrials.gov/show/NCT02875743 |
Completed |
King’s College Hospital NHS Trust |
2018-10-31 |
| NCT02845596 |
Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT02845596 |
Recruiting |
Children’s Hospital Los Angeles |
2020-05-31 |
| NCT02828592 |
Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT02828592 |
Recruiting |
Northside Hospital, Inc. |
2022-08-31 |
| NCT02773290 |
Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT02773290 |
Active, not recruiting |
Kyowa Kirin Co., Ltd. |
2020-12-31 |
| NCT02773225 |
Efficacy and Safety of Eltrombopag + CSA in Patients With Moderate Aplastic Anemia (EMAA) |
https://ClinicalTrials.gov/show/NCT02773225 |
Recruiting |
University of Ulm |
2022-09-30 |
| NCT02745717 |
The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT02745717 |
Recruiting |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2021-12-31 |
| NCT00195624 |
Alemtuzumab to Treat Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00195624 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-04-14 |
| NCT02566304 |
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT02566304 |
Recruiting |
Thomas Jefferson University |
2020-07-23 |
| NCT02404025 |
Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects |
https://ClinicalTrials.gov/show/NCT02404025 |
Completed |
Novartis |
2016-07-05 |
| NCT02162420 |
Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT02162420 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2024-07-31 |
| NCT02148133 |
A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT02148133 |
Completed |
Novartis |
2015-09-10 |
| NCT02099747 |
hATG+CsA vs hATG+CsA+Eltrombopag for SAA |
https://ClinicalTrials.gov/show/NCT02099747 |
Active, not recruiting |
European Group for Blood and Marrow Transplantation |
2019-09-30 |
| NCT02094417 |
A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT02094417 |
Completed |
Kyowa Kirin Korea Co., Ltd. |
2017-04-24 |
| NCT02065869 |
Safety Study of Gene Modified Donor T-cells Following TCR Alpha Beta Depleted Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT02065869 |
Active, not recruiting |
Bellicum Pharmaceuticals |
2020-08-31 |
| NCT02065154 |
Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis |
https://ClinicalTrials.gov/show/NCT02065154 |
Active, not recruiting |
University of Alabama at Birmingham |
2020-04-30 |
| NCT01297972 |
Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01297972 |
Completed |
University of Sao Paulo |
2013-11-30 |
| NCT01966367 |
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01966367 |
Active, not recruiting |
Columbia University |
2022-01-31 |
| NCT01917708 |
Bone Marrow Transplant With Abatacept for Non-Malignant Diseases |
https://ClinicalTrials.gov/show/NCT01917708 |
Completed |
Emory University |
2019-09-19 |
| NCT01891994 |
Extended Dosing With Eltrombopag for Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01891994 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2017-10-16 |
| NCT01861093 |
Safety Study of Cord Blood Units for Stem Cell Transplants |
https://ClinicalTrials.gov/show/NCT01861093 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2037-11-30 |
| NCT01758042 |
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders |
https://ClinicalTrials.gov/show/NCT01758042 |
Recruiting |
Massachusetts General Hospital |
2019-07-31 |
| NCT01703169 |
Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01703169 |
Completed |
University of Utah |
2016-06-30 |
| NCT01659606 |
Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita |
https://ClinicalTrials.gov/show/NCT01659606 |
Recruiting |
Boston Children’s Hospital |
2022-12-31 |
| NCT01624805 |
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT01624805 |
Recruiting |
M.D. Anderson Cancer Center |
2020-06-30 |
| NCT01553461 |
Transplants With Unlicensed Preserved Cord Blood |
https://ClinicalTrials.gov/show/NCT01553461 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2036-10-20 |
| NCT01546415 |
Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01546415 |
Completed |
Novartis |
2013-11-30 |
| NCT01530555 |
Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline®, Genzyme) With Ciclosporin for Patients With Acquired Aplastic Anaemia |
https://ClinicalTrials.gov/show/NCT01530555 |
Completed |
King Faisal Specialist Hospital & Research Center |
2013-07-31 |
| NCT01529827 |
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01529827 |
Completed |
Roswell Park Cancer Institute |
2015-05-28 |
| NCT01499147 |
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT01499147 |
Completed |
University of Illinois at Chicago |
2013-05-31 |
| NCT01441037 |
Danazol for Genetic Bone Marrow and Lung Disorders |
https://ClinicalTrials.gov/show/NCT01441037 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-11-14 |
| NCT01384513 |
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies |
https://ClinicalTrials.gov/show/NCT01384513 |
Recruiting |
Thomas Jefferson University |
2020-12-31 |
| NCT01364363 |
Unrelated Donor Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01364363 |
Recruiting |
Scripps Health |
2021-01-31 |
| NCT01362595 |
Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia |
https://ClinicalTrials.gov/show/NCT01362595 |
Active, not recruiting |
Northwell Health |
2018-06-30 |
| NCT01350245 |
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor |
https://ClinicalTrials.gov/show/NCT01350245 |
Completed |
Thomas Jefferson University |
2013-05-31 |
| NCT01343953 |
Cord Blood Transplantation in Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01343953 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2017-06-30 |
| NCT01328587 |
Eltrombopag for Moderate Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01328587 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2018-03-30 |
| NCT04331483 |
A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts |
https://ClinicalTrials.gov/show/NCT04331483 |
Active, not recruiting |
Centre Leon Berard |
2023-09-30 |
| NCT04304820 |
Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA) |
https://ClinicalTrials.gov/show/NCT04304820 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2023-03-01 |
| NCT04095936 |
Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT04095936 |
Recruiting |
Kyowa Kirin Co., Ltd. |
2020-12-31 |
| NCT03988608 |
Study to Assess the Safety and Efficacy of Eltrombopag in Chinese Refractory or Relapsed Severe Aplastic Anemia (SAA) Subjects. |
https://ClinicalTrials.gov/show/NCT03988608 |
Recruiting |
Novartis |
2021-08-31 |
| NCT03957694 |
Study of AMG531(Romiplostim) in Patients With Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT03957694 |
Active, not recruiting |
Kyowa Kirin Co., Ltd. |
2020-07-31 |
| NCT03896971 |
Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia |
https://ClinicalTrials.gov/show/NCT03896971 |
Recruiting |
Assiut University |
2020-05-01 |
| NCT03904134 |
Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation |
https://ClinicalTrials.gov/show/NCT03904134 |
Recruiting |
Center for International Blood and Marrow Transplant Research |
2024-06-30 |
| NCT03836690 |
Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT03836690 |
Recruiting |
University College, London |
2022-07-01 |
| NCT03733249 |
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study |
https://ClinicalTrials.gov/show/NCT03733249 |
Enrolling by invitation |
Bellicum Pharmaceuticals |
2034-06-30 |
| NCT03622788 |
Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03622788 |
Recruiting |
M.D. Anderson Cancer Center |
2021-07-01 |
| NCT03579875 |
T Cell Receptor α/β TCD HCT in Patients With Fanconi Anemia |
https://ClinicalTrials.gov/show/NCT03579875 |
Recruiting |
Masonic Cancer Center, University of Minnesota |
2026-02-28 |
| NCT03557099 |
A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia (SAA) Patient |
https://ClinicalTrials.gov/show/NCT03557099 |
Recruiting |
Jiangsu HengRui Medicine Co., Ltd. |
2019-10-31 |
| NCT03531736 |
T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT03531736 |
Recruiting |
Memorial Sloan Kettering Cancer Center |
2021-05-31 |
| NCT03520647 |
Haplo-Identical Transplantation for Severe Aplastic Anemia and Hypo-Plastic MDS Using Peripheral Blood Stem Cells and Post-Transplant Cyclophosphamide for GVHD Prophylaxis |
https://ClinicalTrials.gov/show/NCT03520647 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2025-06-01 |
| NCT03413306 |
Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA |
https://ClinicalTrials.gov/show/NCT03413306 |
Recruiting |
Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
2020-10-20 |
| NCT01231841 |
Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01231841 |
Completed |
The Cleveland Clinic |
2010-12-31 |
| NCT01224496 |
Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological Disorders |
https://ClinicalTrials.gov/show/NCT01224496 |
Completed |
Singapore General Hospital |
2011-08-31 |
| NCT01193283 |
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01193283 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-09-30 |
| NCT01187017 |
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01187017 |
Completed |
National Institutes of Health Clinical Center (CC) |
2012-07-31 |
| NCT01105273 |
Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01105273 |
Completed |
Asan Medical Center |
2012-07-31 |
| NCT00997386 |
Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States |
https://ClinicalTrials.gov/show/NCT00997386 |
Completed |
University of Arizona |
2014-04-30 |
| NCT00987480 |
Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine |
https://ClinicalTrials.gov/show/NCT00987480 |
Completed |
Memorial Sloan Kettering Cancer Center |
2017-07-10 |
| NCT00975975 |
Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer |
https://ClinicalTrials.gov/show/NCT00975975 |
Completed |
Indiana University |
2012-10-31 |
| NCT00944749 |
Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment |
https://ClinicalTrials.gov/show/NCT00944749 |
Completed |
National Institutes of Health Clinical Center (CC) |
2015-12-31 |
| NCT00922883 |
A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients |
https://ClinicalTrials.gov/show/NCT00922883 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2013-05-07 |
| NCT00856388 |
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders |
https://ClinicalTrials.gov/show/NCT00856388 |
Completed |
Roswell Park Cancer Institute |
2012-08-09 |
| NCT02833805 |
NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT02833805 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2020-08-31 |
| NCT02224872 |
Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT02224872 |
Active, not recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2023-11-30 |
| NCT03192397 |
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03192397 |
Recruiting |
Roswell Park Cancer Institute |
2021-07-01 |
| NCT01586455 |
Human Placental-Derived Stem Cell Transplantation |
https://ClinicalTrials.gov/show/NCT01586455 |
Active, not recruiting |
New York Medical College |
2019-06-30 |
| NCT00806598 |
Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00806598 |
Completed |
M.D. Anderson Cancer Center |
2012-06-30 |
| NCT01623167 |
Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT01623167 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2018-01-30 |
| NCT01174108 |
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells |
https://ClinicalTrials.gov/show/NCT01174108 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2021-06-30 |
| NCT03301168 |
Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03301168 |
Active, not recruiting |
Bellicum Pharmaceuticals |
2020-02-29 |
| NCT03047746 |
Unrelated And Partially Matched Related Donor PSCT w/ TCR αβ Depletion for Patients With BMF |
https://ClinicalTrials.gov/show/NCT03047746 |
Recruiting |
Children’s Hospital of Philadelphia |
2022-01-31 |
| NCT03955601 |
A Novel TBI Free Conditioning Protocol for Haploidentical Transplant in Acquired Aplastic Anemia: |
https://ClinicalTrials.gov/show/NCT03955601 |
Recruiting |
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan |
2020-12-30 |
| NCT00774527 |
Comparison of Cy-Atg Vs Cy-Flu-Atg for the Conditioning Therapy in Allo-HCT |
https://ClinicalTrials.gov/show/NCT00774527 |
Completed |
Cooperative Study Group A for Hematology |
2010-02-28 |
| NCT00692926 |
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells |
https://ClinicalTrials.gov/show/NCT00692926 |
Completed |
Duke University |
2012-07-31 |
| NCT00683046 |
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies |
https://ClinicalTrials.gov/show/NCT00683046 |
Completed |
University of Chicago |
2014-12-31 |
| NCT00636909 |
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00636909 |
Completed |
Beth Israel Deaconess Medical Center |
2006-03-31 |
| NCT00618969 |
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors |
https://ClinicalTrials.gov/show/NCT00618969 |
Completed |
University of Arizona |
2013-12-31 |
| NCT00604201 |
Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelopdysplastic Syndrome |
https://ClinicalTrials.gov/show/NCT00604201 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
2016-10-25 |
| NCT00578266 |
Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00578266 |
Completed |
Mayo Clinic |
2016-08-16 |
| NCT00533923 |
Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00533923 |
Completed |
Beth Israel Deaconess Medical Center |
2007-01-31 |
| NCT00516152 |
Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT |
https://ClinicalTrials.gov/show/NCT00516152 |
Completed |
University of California, San Francisco |
NA |
| NCT00455312 |
Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA |
https://ClinicalTrials.gov/show/NCT00455312 |
Completed |
Masonic Cancer Center, University of Minnesota |
2015-03-31 |
| NCT00427336 |
Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00427336 |
Completed |
M.D. Anderson Cancer Center |
2009-08-31 |
| NCT00358657 |
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders |
https://ClinicalTrials.gov/show/NCT00358657 |
Active, not recruiting |
Fred Hutchinson Cancer Research Center |
2023-12-01 |
| NCT00343785 |
Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant |
https://ClinicalTrials.gov/show/NCT00343785 |
Completed |
Fred Hutchinson Cancer Research Center |
2012-05-31 |
| NCT00326417 |
Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) |
https://ClinicalTrials.gov/show/NCT00326417 |
Completed |
Medical College of Wisconsin |
2015-09-30 |
| NCT00260689 |
Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00260689 |
Completed |
National Institutes of Health Clinical Center (CC) |
2016-05-04 |
| NCT00244010 |
Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias |
https://ClinicalTrials.gov/show/NCT00244010 |
Completed |
St. Jude Children’s Research Hospital |
2008-11-30 |
| NCT00243399 |
Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia |
https://ClinicalTrials.gov/show/NCT00243399 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
2009-12-31 |
| NCT00229619 |
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia |
https://ClinicalTrials.gov/show/NCT00229619 |
Completed |
National Institutes of Health Clinical Center (CC) |
2010-06-30 |
| NCT00186797 |
Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00186797 |
Completed |
St. Jude Children’s Research Hospital |
2005-09-30 |
| NCT00144729 |
Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor |
https://ClinicalTrials.gov/show/NCT00144729 |
Completed |
Fred Hutchinson Cancer Research Center |
NA |
| NCT00065260 |
Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00065260 |
Completed |
National Institutes of Health Clinical Center (CC) |
2014-12-31 |
| NCT00061763 |
Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias |
https://ClinicalTrials.gov/show/NCT00061763 |
Completed |
Novartis |
2004-11-30 |
| NCT00061360 |
Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00061360 |
Completed |
National Institutes of Health Clinical Center (CC) |
2005-11-15 |
| NCT00054236 |
Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00054236 |
Completed |
Case Comprehensive Cancer Center |
2011-03-31 |
| NCT00053989 |
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders |
https://ClinicalTrials.gov/show/NCT00053989 |
Completed |
Roswell Park Cancer Institute |
2018-07-19 |
| NCT00004143 |
Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes |
https://ClinicalTrials.gov/show/NCT00004143 |
Completed |
Duke University |
2008-05-31 |
| NCT00003816 |
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer |
https://ClinicalTrials.gov/show/NCT00003816 |
Completed |
Roswell Park Cancer Institute |
2019-07-12 |
| NCT00673114 |
Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies |
https://ClinicalTrials.gov/show/NCT00673114 |
Completed |
Duke University |
2012-04-30 |
| NCT00011830 |
Stem Cell Mobilization Potential in Patients With Aplastic Anemia in Remission |
https://ClinicalTrials.gov/show/NCT00011830 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00005935 |
Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00005935 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00001964 |
Combination Therapy of Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00001964 |
Completed |
National Institutes of Health Clinical Center (CC) |
2003-12-09 |
| NCT00001626 |
Comparing Therapies for the Treatment of Severe Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00001626 |
Completed |
National Institutes of Health Clinical Center (CC) |
2001-02-20 |
| NCT00001398 |
Stem Cell Factor Medication for Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00001398 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00000603 |
Cord Blood Stem Cell Transplantation Study (COBLT) |
https://ClinicalTrials.gov/show/NCT00000603 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2007-10-31 |
| NCT00000597 |
Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders |
https://ClinicalTrials.gov/show/NCT00000597 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00004474 |
Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00004474 |
Completed |
Office of Rare Diseases (ORD) |
2007-08-31 |
| NCT00004464 |
Study of High Dose Cyclophosphamide in Patients With Severe Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria |
https://ClinicalTrials.gov/show/NCT00004464 |
Completed |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2007-03-01 |
| NCT00004323 |
Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia |
https://ClinicalTrials.gov/show/NCT00004323 |
Completed |
National Center for Research Resources (NCRR) |
NA |